Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde-derived advanced glycation end-product formation.
about
Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related DiseasesOcular diseases: immunological and molecular mechanismsMoving forward in uveitis therapy: preclinical to phase II clinical trial drug development.Reactive Carbonyl Species Scavengers-Novel Therapeutic Approaches for Chronic Diseases.
P2860
Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde-derived advanced glycation end-product formation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Amelioration of experimental a ...... ycation end-product formation.
@en
Amelioration of experimental a ...... ycation end-product formation.
@nl
type
label
Amelioration of experimental a ...... ycation end-product formation.
@en
Amelioration of experimental a ...... ycation end-product formation.
@nl
prefLabel
Amelioration of experimental a ...... ycation end-product formation.
@en
Amelioration of experimental a ...... ycation end-product formation.
@nl
P2093
P1476
Amelioration of experimental a ...... lycation end-product formation
@en
P2093
Atsuhiro Kanda
Daiju Iwata
Junichi Fukuhara
Kazuomi Mizuuchi
Kazuya Iwabuchi
Kenichi Namba
Kousuke Noda
Masashi Sato
Masayoshi Takeuchi
Mizuki Kitamura
P304
P356
10.1189/JLB.3A0513-288RRR
P577
2014-09-08T00:00:00Z